Monitoring liver tumor therapy with [18F]FDG positron emission tomography

Y Nagata; K Yamamoto; M Hiraoka; M Abe; M Takahashi; K Akuta; Y Nishimura; S Jo; S Masunaga; S Kubo

Monitoring liver tumor therapy with [18F]FDG positron emission tomography

J Comput Assist Tomogr. 1990 May-Jun;14(3):370-4.

Authors

Y Nagata¹, K Yamamoto, M Hiraoka, M Abe, M Takahashi, K Akuta, Y Nishimura, S Jo, S Masunaga, S Kubo, et al.

Affiliation

¹ Department of Radiology, Kyoto University Hospital, Japan.

PMID: 2335602

Abstract

Positron emission tomography (PET) with [18F]-2-flurodeoxy-glucose (FDG) can be utilized as a functional imaging modality for monitoring liver tumor therapy. We report three cases in which PET-FDG was more useful for this purpose than other imaging methods and tumor markers.

Publication types

Case Reports

MeSH terms

Adult
Deoxy Sugars*
Deoxyglucose* / analogs & derivatives
Embolization, Therapeutic
Female
Fluorine Radioisotopes*
Fluorodeoxyglucose F18
Humans
Liver Neoplasms / diagnostic imaging
Liver Neoplasms / secondary
Liver Neoplasms / therapy*
Male
Middle Aged
Monitoring, Physiologic
Neoplasm Recurrence, Local
Tomography, Emission-Computed*
Tomography, X-Ray Computed

Substances

Deoxy Sugars
Fluorine Radioisotopes
Fluorodeoxyglucose F18
Deoxyglucose